![Melanoma / Organochlorides / Organofluorides / Sulfonamides / Vemurafenib / BRAF / Ipilimumab / Dacarbazine / End point of clinical trials / Medicine / Chemistry / Oncology Melanoma / Organochlorides / Organofluorides / Sulfonamides / Vemurafenib / BRAF / Ipilimumab / Dacarbazine / End point of clinical trials / Medicine / Chemistry / Oncology](https://www.pdfsearch.io/img/2abb93095cafdb1d23e46c8d7d752b2e.jpg)
| Document Date: 2014-10-01 21:56:23 Open Document File Size: 94,43 KBShare Result on Facebook
Company GlaxoSmithKline Australia Pty Ltd / / Country Australia / / Currency USD / / IndustryTerm Therapies for advanced melanoma / treatment of advanced or metastatic melanoma / study protocols / / MedicalCondition melanoma / cut / III disease / Proposed Therapy Melanomas / squamous cell carcinoma / aggressive and invasive disease / disease / brain metastases / Stable disease / cutaneous squamous cell carcinoma / metastasis / progressive disease / IV melanoma / malignant tumours / cutaneous squamous cell carcinomas / Advanced melanoma / Severe neutropenia / metastatic melanoma / / MedicalTreatment radiotherapy / surgery / radiation / / Organization World Health Organization / Listing Requested and PBAC’s View Authority / / Position author / / Product dacarbazine / / Technology radiation / pharmacogenetics / study protocols / /
SocialTag |